Search Results


  1. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond

    Drug and Alcohol Review

    Volume 34, Issue 4, July 2015, Pages: 404–411, Simon Lenton, Paul Dietze, Anna Olsen, Nicole Wiggins, David McDonald and Carrie Fowlie

    Version of Record online : 1 OCT 2014, DOI: 10.1111/dar.12198

  2. REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade

    Addiction Biology

    Volume 12, Issue 3-4, September 2007, Pages: 227–462, Thomas M. Tzschentke

    Version of Record online : 30 JUL 2007, DOI: 10.1111/j.1369-1600.2007.00070.x

  3. Naloxone—does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose


    Volume 110, Issue 10, October 2015, Pages: 1644–1652, Joanne Neale and John Strang

    Version of Record online : 30 JUL 2015, DOI: 10.1111/add.13027

  4. You have free access to this content
    Naloxone reversal of an overdose of a novel, long-acting transdermal fentanyl solution in laboratory Beagles

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 35, Issue s2, August 2012, Pages: 45–51, K. J. FREISE, G. C. NEWBOUND, C. TUDAN and T. P. CLARK

    Version of Record online : 25 JUN 2012, DOI: 10.1111/j.1365-2885.2012.01409.x

  5. You have free access to this content
    Protein kinase C phosphorylates the cAMP response element binding protein in the hypothalamic paraventricular nucleus during morphine withdrawal

    British Journal of Pharmacology

    Volume 163, Issue 4, June 2011, Pages: 857–875, F Martín, L Mora, ML Laorden and MV Milanés

    Version of Record online : 26 MAY 2011, DOI: 10.1111/j.1476-5381.2011.01287.x

  6. You have full text access to this OnlineOpen article
    Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain

    International Journal of Clinical Practice

    Volume 64, Issue 6, May 2010, Pages: 763–774, A. Sandner-Kiesling, P. Leyendecker, M. Hopp, L. Tarau, J. Lejcko, W. Meissner, P. Sevcik, M. Hakl, R. Hrib, R. Uhl, H. Dürr and K. Reimer

    Version of Record online : 29 MAR 2010, DOI: 10.1111/j.1742-1241.2010.02360.x

  7. Anatomical distribution of sodium-dependent [3H]naloxone binding sites in rat brain


    Volume 35, Issue 4, 15 March 2000, Pages: 256–264, Laura J. Sim-Selley, Ruoyu Xiao and Steven R. Childers

    Version of Record online : 2 FEB 2000, DOI: 10.1002/(SICI)1098-2396(20000315)35:4<256::AID-SYN3>3.0.CO;2-7

  8. Methadone-naloxone mixtures for use in methadone maintenance programs; I. An evaluation in man of their pharmacological feasibility; II. Demonstration of acute physical dependence

    Clinical Pharmacology & Therapeutics

    Volume 15, Issue 2, February 1974, Pages: 156–166, John G. Nutt and Donald R. Jasinski

    Version of Record online : 4 JAN 2016, DOI: 10.1002/cpt1974152156

  9. Effects of Naloxone on Gonadotropin Secretion in Klinefelter Syndrome


    Volume 16, Issue 5, September-October 1984, Pages: 397–405, C. FORESTA, G.F. MENCHINI FABRIS, R. MIONI, N. SICOLO and C. SCANDELLARI

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1439-0272.1984.tb00382.x

  10. You have free access to this content
    Release of Oxytocin into Blood and into Cerebrospinal Fluid Induced by Naloxone in Anaesthetized Morphine-Dependent Rats: The Role of the Paraventricular Nucleus

    Journal of Neuroendocrinology

    Volume 3, Issue 5, October 1991, Pages: 551–561, J. E. Coombes, I. C. A. F. Robinson, F. A. Antoni and J. A. Russell

    Version of Record online : 29 SEP 2006, DOI: 10.1111/j.1365-2826.1991.tb00316.x

  11. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers


    Volume 105, Issue 4, April 2010, Pages: 709–718, Sandra D. Comer, Maria A. Sullivan, Suzanne K. Vosburg, Jeanne Manubay, Leslie Amass, Ziva D. Cooper, Phillip Saccone and Herbert D. Kleber

    Version of Record online : 10 MAR 2010, DOI: 10.1111/j.1360-0443.2009.02843.x

    Corrected by:


    Vol. 105, Issue 7, 1322, Version of Record online: 8 JUN 2010

  12. Risk Predictors of Opioid-Induced Critical Respiratory Events in Children: Naloxone Use as a Quality Measure of Opioid Safety

    Pain Medicine

    Volume 15, Issue 12, December 2014, Pages: 2139–2149, Vidya Chidambaran, Vanessa Olbrecht, Monir Hossain, Senthilkumar Sadhasivam, John Rose and Mark J. Meyer

    Version of Record online : 15 OCT 2014, DOI: 10.1111/pme.12575

  13. Phosphodiesterase inhibition by naloxone augments the inotropic actions of β-adrenergic stimulation

    Acta Anaesthesiologica Scandinavica

    Volume 53, Issue 8, September 2009, Pages: 1043–1051, W. K. PARK, C. H. CHANG, J. E. CHAE, M. H. KIM, Y. L. CHO and D. S. AHN

    Version of Record online : 30 JUN 2009, DOI: 10.1111/j.1399-6576.2009.02023.x

  14. You have free access to this content
    Emergency Medical Services Naloxone Access: A National Systematic Legal Review

    Academic Emergency Medicine

    Volume 21, Issue 10, October 2014, Pages: 1173–1177, Corey S. Davis, Jessica K. Southwell, Virginia Radford Niehaus, Alexander Y. Walley and Michael W. Dailey

    Version of Record online : 10 OCT 2014, DOI: 10.1111/acem.12485

  15. You have full text access to this OnlineOpen article
    Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-label, Phase 3b/4 Trial

    Pain Practice

    Volume 16, Issue 5, June 2016, Pages: 600–619, Ralf Baron, Jan-Peter Jansen, Andreas Binder, Manuel Pombo-Suarez, Lieven Kennes, Matthias Müller, Dietmar Falke and Ilona Steigerwald

    Version of Record online : 11 NOV 2015, DOI: 10.1111/papr.12361

  16. You have free access to this content
    Endogenous Opioids Modulate the Oxytocin Response to Insulin-Induced Hypoglycaemia and Partially Mediate the Inhibitory Effect of Ethanol in Man

    Journal of Neuroendocrinology

    Volume 3, Issue 4, August 1991, Pages: 401–405, V. Coiro, L. Capretti, C. Davoli, G. SperoniJ, L. Bianconi, U. Cavazzini, A. Marcato, C. Papadia, R. Volpi and P. Chioderat

    Version of Record online : 29 SEP 2006, DOI: 10.1111/j.1365-2826.1991.tb00294.x

  17. You have free access to this content
    Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence

    British Journal of Pharmacology

    Volume 145, Issue 7, August 2005, Pages: 975–983, Ellen A Walker and Steven N Sterious

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706247

  18. Urine naloxone concentration at different phases of buprenorphine maintenance treatment

    Drug Testing and Analysis

    Volume 6, Issue 3, March 2014, Pages: 220–225, Pertti Heikman, Margareeta Häkkinen, Merja Gergov and Ilkka Ojanperä

    Version of Record online : 19 MAR 2013, DOI: 10.1002/dta.1464

  19. Endogenous opioid peptide system in male brown bullhead catfish, Ictalurus nebulosus lesueur: Characterization of naloxone binding and the response to naloxone during the annual reproductive cycle

    Journal of Experimental Zoology

    Volume 245, Issue 3, March 1988, Pages: 244–255, Paul M. Rosenblum and Ian P. Callard

    Version of Record online : 16 MAY 2005, DOI: 10.1002/jez.1402450304

  20. Antagonism of Fentanyl with Naloxone during N2O+O2+ Halothane Anaesthesia

    Acta Anaesthesiologica Scandinavica

    Volume 21, Issue 6, December 1977, Pages: 470–480, Irma Tigerstedt

    Version of Record online : 30 DEC 2008, DOI: 10.1111/j.1399-6576.1977.tb01248.x